Ignite Creation Date:
2024-05-06 @ 4:18 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04943497
Status:
RECRUITING
Last Update Posted:
2024-02-22
First Post:
2021-06-21
Brief Title:
A Prospective Observational Study to Describe Clinical Outcomes Treatment Patterns Patients Characteristics Among Patients With HRHER2- Advanced BC Initiating Treatment With Risarg Piqray Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis